Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6be7b5f316f050e9151b3afd8936f7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2017-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69c3bc4a43030ae1232de13fe8a3ed22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99745f780006df4a0fc05a51208d634a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705d2b7b18f23dfab3f3a3b035748813 |
publicationDate |
2020-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020095326-A1 |
titleOfInvention |
Combination of ant-cd303 and anti-amhrii antibodies |
abstract |
Disclosed is a pharmaceutical composition including, in a pharmaceutically acceptable carrier: at least one anti-CD303 antibody; and at least one anti-AMHRII antibody. Also disclosed is the combination of the two aforementioned antibodies a) and b) to form a combination product to be used simultaneously, separately or spread out over a period of time, for the prevention or treatment of urogenital cancers. Also disclosed is a method for preventing or treating an urogenital cancer in a subject in need thereof, such method including administering to the subject products containing: at least one anti-CD303 antibody; and at least one anti-AMHRII antibody. |
priorityDate |
2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |